Amy Grahn
About
Amy Grahn is a scholar working on Pharmacology, Surgery and Rheumatology.
According to data from OpenAlex, Amy Grahn has authored 23 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 7 papers in Surgery and 5 papers in Rheumatology. Recurrent topics in Amy Grahn's work include Inflammatory mediators and NSAID effects (9 papers), Helicobacter pylori-related gastroenterology studies (6 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). Amy Grahn is often cited by papers focused on Inflammatory mediators and NSAID effects (9 papers), Helicobacter pylori-related gastroenterology studies (6 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). Amy Grahn collaborates with scholars based in United States, Germany and United Kingdom. Amy Grahn's co-authors include Alfonso E. Bello, Jeffrey W. Sherman, Alan Kivitz, Loren Laine, Robert J. Holt, Michael Schiff, Ali S. Taha, Patricia Rice, Frederick F. Lang and Michael A. Vogelbaum and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Gut.
In The Last Decade
Amy Grahn
19 papers receiving 454 citations
Peers
Amy Grahn
Claire M.F. Potter United Kingdom
Xuebin Fu United States
Ayumi Aurea Miyakawa Brazil
V. I. Zemelko Russia
Ruth Greferath United States
Jinbeom Heo South Korea
Olivia Cochet France
Sergey Magnitsky United States
Shangfu Li China
Citations per year, relative to Amy Grahn Amy Grahn (= 1×)
peers
Claire M.F. Potter
Countries citing papers authored by Amy Grahn
Since
Specialization
Citations
This map shows the geographic impact of Amy Grahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Grahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Grahn more than expected).
Fields of papers citing papers by Amy Grahn
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Amy Grahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Grahn. The network helps show where Amy Grahn may publish in the future.
Co-authorship network of co-authors of Amy Grahn
This figure shows the co-authorship network connecting the top 25 collaborators of Amy Grahn. A scholar is included among the top collaborators of Amy Grahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Grahn. Amy Grahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Lynch, David R., Lauren Hauser, Yi Dong, et al.. (2019). Randomized, double‐blind, placebo‐controlled study of interferon‐γ 1b in Friedreich Ataxia. Annals of Clinical and Translational Neurology. 6(3). 546–553.
2.
Alten, Rieke, Robert J. Holt, Amy Grahn, et al.. (2015). Morning stiffness response with delayed-release prednisone after ineffective course of immediate-release prednisone. Scandinavian Journal of Rheumatology. 44(5). 354–358.
3.
Holt, Robert J., John G. Fort, Amy Grahn, Jeffrey D. Kent, & Alfonso E. Bello. (2015). Onset and durability of pain relief in knee osteoarthritis: Pooled results from two placebo trials of naproxen/esomeprazole combination and celecoxib. The Physician and Sportsmedicine. 43(3). 200–212.
4.
Buttgereit, Frank, Jeffrey D. Kent, Robert J. Holt, et al.. (2015). Improvement Thresholds for Morning Stiffness Duration in Patients Receiving Delayed- Versus Immediate-Release Prednisone for Rheumatoid Arthritis.. PubMed. 73(3). 168–77.
5.
Alten, Rieke, Amy Grahn, Robert J. Holt, Patricia Rice, & Frank Buttgereit. (2015). Delayed-release prednisone improves fatigue and health-related quality of life: findings from the CAPRA-2 double-blind randomised study in rheumatoid arthritis. RMD Open. 1(1). e000134–e000134.
6.
Boers, Maarten, Frank Buttgereit, Kenneth G. Saag, et al.. (2015). What Is the Relationship Between Morning Symptoms and Measures of Disease Activity in Patients With Rheumatoid Arthritis?. Arthritis Care & Research. 67(9). 1202–1209.
7.
Holt, Robert J., Donald Jung, George F. Tidmarsh, et al.. (2014). Pharmacodynamic evaluation of intragastric pH and implications for famotidine dosing in the prophylaxis of non-steroidal anti-inflammatory drug induced gastropathy—a proof of concept analysis. PubMed. 3(1). 20–27.
8.
Bello, Alfonso E., Jeffrey D. Kent, Amy Grahn, Patricia Rice, & Robert J. Holt. (2014). Risk of Upper Gastrointestinal Ulcers in Patients With Osteoarthritis Receiving Single-Tablet Ibuprofen/Famotidine Versus Ibuprofen Alone: Pooled Efficacy and Safety Analyses of Two Randomized, Double-Blind, Comparison Trials. Postgraduate Medicine. 126(4). 82–91.
9.
Bello, Alfonso E., Amy Grahn, Julie Ball, Jeffrey D. Kent, & Robert J. Holt. (2014). One-year safety of ibuprofen/famotidine fixed combination versus ibuprofen alone: pooled analyses of two 24-week randomized, double-blind trials and a follow-on extension. Current Medical Research and Opinion. 31(3). 407–420.
10.
Bello, Alfonso E., Jeffrey D. Kent, Amy Grahn, Julie Ball, & Robert J. Holt. (2014). One-year open-label safety evaluation of the fixed combination of ibuprofen and famotidine with a prospective analysis of dyspepsia. Current Medical Research and Opinion. 31(3). 397–405.
11.
Goldstein, Jay L., Sharad Lakhanpal, Stanley M. Cohen, et al.. (2012). Decreased NSAID Associated Treatment Emergent Dyspepsia and Increased Patient Satisfaction Associated with Ibuprofen/Famotidine Combination Tablet: SODA Results from a 12-Month Trial. The American Journal of Gastroenterology. 107. S52–S53.
12.
Laine, Loren, Alan Kivitz, Alfonso E. Bello, et al.. (2011). Double-Blind Randomized Trials of Single-Tablet Ibuprofen/High-Dose Famotidine vs. Ibuprofen Alone for Reduction of Gastric and Duodenal Ulcers. The American Journal of Gastroenterology. 107(3). 379–386.
13.
Taha, Ali S., Loren Laine, & Amy Grahn. (2011). Reducing the incidence of peptic ulcers with ibuprofen-famotidine combined pill, HZT-501 (reduce): phase-III, double-blind multi-centre trials: Figure 1. Gut. 60(Suppl 1). A8.2–A9.
14.
Goldstein, Jay L., Sharad Lakhanpal, Stanley Cohen, et al.. (2011). Long Term Safety of an NSAID With Built-in Gastroprotection for Treatment of Pain and Inflammation Related to Oa and RA: Comparative Results From Blinded and Open Label One Year Safety Trials of a Single-Tablet Combination of Ibuprofen-Famotidine. Gastroenterology. 140(5). S–585.
15.
Grahn, Amy, Krystof S. Bankiewicz, Millicent M. Dugich‐Djordjevic, et al.. (2009). Non-PEGylated liposomes for convection-enhanced delivery of topotecan and gadodiamide in malignant glioma: initial experience. Journal of Neuro-Oncology. 95(2). 185–197.
16.
Fetterly, Gerald J., Thaddeus H. Grasela, Jeffrey W. Sherman, et al.. (2008). Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Neutropenia during Phase I Development of Liposome-Entrapped Paclitaxel. Clinical Cancer Research. 14(18). 5856–5863.
17.
Vogelbaum, Michael A., John H. Sampson, Sandeep Kunwar, et al.. (2007). CONVECTION-ENHANCED DELIVERY OF CINTREDEKIN BESUDOTOX (INTERLEUKIN-13-PE38QQR) FOLLOWED BY RADIATION THERAPY WITH AND WITHOUT TEMOZOLOMIDE IN NEWLY DIAGNOSED MALIGNANT GLIOMAS. Neurosurgery. 61(5). 1031–1038.
18.
Damjanov, Nevena, Mayer Fishman, Gerald J. Fetterly, et al.. (2005). Final results of a Phase I study of Liposome Entrapped Paclitaxel (LEP-ETU) in patients with advanced cancer. Journal of Clinical Oncology. 23(16_suppl). 2048–2048.
19.
Verhaar, Marianne C., Amy Grahn, Marina L. H. Honing, et al.. (2000). Pharmacokinetics and pharmacodynamic effects of ABT‐627, an oral ETA selective endothelin antagonist, in humans. British Journal of Clinical Pharmacology. 49(6). 562–573.
20.
Grahn, Amy, et al.. (1990). Suitability of the dog as an animal model for evaluating theophylline absorption and food effects from different formulations. International Journal of Pharmaceutics. 60(2). 125–132.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Claire M.F. Potter Breakdown of academic impact, for papers by Xuebin Fu Breakdown of academic impact, for papers by Ayumi Aurea Miyakawa Breakdown of academic impact, for papers by V. I. Zemelko Breakdown of academic impact, for papers by Ruth Greferath Breakdown of academic impact, for papers by Jinbeom Heo Breakdown of academic impact, for papers by Olivia Cochet Breakdown of academic impact, for papers by Sergey Magnitsky Breakdown of academic impact, for papers by Shangfu Li